XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,539 | -72.5% | 116,956 | -61.3% | 0.00% | – |
| Q2 2023 | $792,172 | -36.6% | 302,356 | -60.5% | 0.00% | – |
| Q1 2023 | $1,249,000 | +991169.8% | 766,291 | +711.6% | 0.00% | – |
| Q4 2022 | $126 | -99.9% | 94,418 | +12.0% | 0.00% | – |
| Q3 2022 | $132,000 | +7.3% | 84,322 | +5.9% | 0.00% | – |
| Q2 2022 | $123,000 | +156.2% | 79,610 | +326.7% | 0.00% | – |
| Q1 2022 | $48,000 | +23.1% | 18,655 | +40.7% | 0.00% | – |
| Q4 2021 | $39,000 | – | 13,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
| Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
| MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
| Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
| EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
| DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
| Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
| Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
| IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |